Deborah R Kaye, MD, MS
Affiliations: | 2009-2010 | National Cancer Institute, Rockville, MD, United States | |
| 2018- | Urology | Duke University Medical School, Durham, NC, United States |
Google:
"Deborah Kaye"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Moses KA, Sprenkle PC, Bahler C, et al. (2023) NCCN GuidelinesĀ® Insights: Prostate Cancer Early Detection, Version 1.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 236-246 |
| Kaye DR, Lee HJ, Gordee A, et al. (2023) Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. Jco Oncology Practice. OP2200645 |
| Wilcox Vanden Berg RN, George AK, Kaye DR. (2022) Should Transperineal Prostate Biopsy Be the Standard of Care? Current Urology Reports |
| Sessine MS, Das S, Park B, et al. (2021) Initial Findings from a High Genetic Risk Prostate Cancer Clinic. Urology |
| Ginsburg KB, Jacobs JC, Qi J, et al. (2020) Impact of Early Confirmatory Tests on Upgrading and Conversion to Treatment in Prostate Cancer Patients on Active Surveillance. Urology |
| Ginsburg KB, Arcot R, Qi J, et al. (2019) Confirmatory MRI With or Without Biopsy Impacts Decision-Making in Newly Diagnosed Favorable Risk Prostate Cancer. The Journal of Urology |
| Kaye D, Zhu Z, Ellimoottil C, et al. (2019) Pd58-07 Health System Characteristics And The Quality Of Urological Cancer Care At The End Of Life The Journal of Urology. 201 |
| Arcot R, Ginsburg K, Qi J, et al. (2019) Pd55-07 Mri With Or Without Biopsy As A Confirmatory Test In Newly Diagnosed Favorable Risk Prostate Cancer Aids In Decision-Making The Journal of Urology. 201 |
| Herrel L, Zhu Z, Kaye D, et al. (2019) Mp44-08 Quality Of Urological Cancer Care At The End Of Life For Dual Eligible Beneficiaries And The Impact Of Delivery System Integration The Journal of Urology. 201 |
| Hu JC, Tosoian JJ, Qi J, et al. (2018) Clinical Utility of Gene Expression Classifiers in Men With Newly Diagnosed Prostate Cancer. Jco Precision Oncology. 2 |